**["Anthropic Will Become the Only Company" Sparks Debate, Dalio Responds: AI Naturally Centralizes, Regulation Is the Remedy]** According to monitoring by Beating, investor Gavin Baker stated on the *All-In Podcast* that several trusted sources told him Dario Amodei once said Anthropic might one day become "the world's only private company." Anthropic researcher Sholto Douglas immediately denied this, calling the claim "completely false" and accusing Baker's sources of lying. Baker accepted the clarification but continued to press the issue. He argued that the rumor gained traction because it aligns with Dario's long-standing public stance: AI is dangerous, power may become highly concentrated, and regulation is necessary. Baker holds the opposite view: the more dangerous AI becomes, the more its capabilities should be decentralized, rather than handed over to a few companies or governments. Dario later personally responded but avoided addressing the "only company" remark directly. He explained that AI will naturally concentrate among a few giants due to chips, computational power, and economies of scale. Open-sourcing model weights might allow more people access to models but won't solve the issue of who has the ability to train the most powerful models. Thus, his solution is regulation, particularly targeting the strongest players: rigorous testing for frontier models, less oversight for smaller companies and followers. Open-sourcing weights can remain, but when capabilities approach the frontier, testing should still apply. Baker worries regulation will create more concentration, while Dario believes regulation is precisely the tool to counteract concentration. He also addressed Baker's criticism that he "always talks about AI risks." Dario argued that public distrust of AI companies stems not from excessive discussion of risks but from the industry's overpromising and underdelivering. Constantly promoting "AI can cure cancer" is meaningless—actually curing cancer is what matters. Anthropic is ramping up efforts in biology and healthcare, hoping to see some early results in the coming months. [Original Link]